Helen Rizos

Professor

  • 2989 Citations
  • 34 h-Index
1989 …2022
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Melanoma Medicine & Life Sciences
Tumor Suppressor Protein p14ARF Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Mitogen-Activated Protein Kinase Kinases Medicine & Life Sciences
Tumors Chemical Compounds
Mutation Medicine & Life Sciences
Melanocytes Medicine & Life Sciences
Mitogen-Activated Protein Kinases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2022

Research Output 1989 2019

Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients

Lee, H., Quek, C., Silva, I., Tasker, A., Batten, M., Rizos, H., Lim, S. Y., Nur Gide, T., Shang, P., Attrill, G. H., Madore, J., Edwards, J., Carlino, M. S., Guminski, A., Saw, R. P. M., Thompson, J. F., Ferguson, P. M., Palendira, U., Menzies, A. M., Long, G. V. & 2 othersScolyer, R. A. & Wilmott, J. S., Feb 2019, In : OncoImmunology. 8, 2, p. 1-10 10 p., e1537581.

Research output: Contribution to journalArticleResearchpeer-review

Natural Killer Cells
Melanoma
Major Histocompatibility Complex
Therapeutics
Neoplasms

Association between circulating tumor DNA and pseudoprogression in patients with metastatic melanoma treated with anti–programmed cell death 1 antibodies

Lee, J. H., Long, G. V., Menzies, A. M., Lo, S., Guminski, A., Whitbourne, K., Peranec, M., Scolyer, R., Kefford, R. F., Rizos, H. & Carlino, M. S., 1 May 2018, In : JAMA Oncology. 4, 5, p. 717-721 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Melanoma
Cell Death
Antibodies
DNA
Neoplasms

Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-PD-1 based immunotherapy

Lim, S. Y., Lee, J. H., Nur Gide, T., Menzies, A. M., Guminski, A., Carlino, M. S., Breen, E., Yang, J. Y. H., Ghazanfar, S., Kefford, R. F., Scolyer, R. A., Long, G. V. & Rizos, H., 8 Nov 2018, In : Clinical Cancer Research.

Research output: Contribution to journalArticleResearchpeer-review

Immunotherapy
Melanoma
Cytokines
Confidence Intervals
Therapeutics

Evaluation of commercial kits for purification of circulating free DNA

Diefenbach, R. J., Lee, J. H., Kefford, R. F. & Rizos, H., 21 Sep 2018, In : Cancer Genetics. 228-229, p. 21-27

Research output: Contribution to journalArticleResearchpeer-review

DNA
Nucleic Acids
Workflow
Plasma Cells
Serum

HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma

Gallagher, S. J., Gunatilake, D., Beaumont, K. A., Sharp, D. M., Tiffen, J. C., Heinemann, A., Weninger, W., Haass, N. K., Wilmott, J. S., Madore, J., Ferguson, P. M., Rizos, H. & Hersey, P., 1 May 2018, In : International Journal of Cancer. 142, 9, p. 1926-1937 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Histone Deacetylase Inhibitors
Phosphatidylinositol 3-Kinases
Melanoma
Survival
Mutation

Prizes